Skip to content

Establishing Guidelines for Manual Lymphatic Drainage

Establishing Guidelines for Manual Lymphatic Drainage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05509062
Acronym
MLD
Enrollment
64
Registered
2022-08-19
Start date
2022-07-20
Completion date
2023-04-30
Last updated
2024-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema of Leg

Brief summary

The purpose of this study is to establish optimal guidelines for Manual Lymphatic Drainage in participants with lower extremity lymphedema.

Detailed description

To determine if there is a difference in L-Dex Score and Segmental Limb Volume in participants with lower extremity lymphedema as measured in liters by the SOZO machine between participants who receive Manual Lymphatic Drainage (MLD) techniques utilizing light tactile pressure with 5-10 mmHg without skin stretch versus medium tactile pressure of 11-20 mmHg and medium skin stretch with therapist in a stationary position, versus firm tactile pressure (\> 21 mmHg) and maximal skin stretch with therapist weight shift.

Interventions

PROCEDUREPressure

Subjects are randomized to one of three treatment groups

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Treatment Group 1 Treatment Group 2 Treatment Group 3

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* All adults between the age of 30 - 75 years * Lower extremity lymphedema

Exclusion criteria

* Pregnant women * Participants who are unable to stand independently for up to 2 mins * Participants who cannot make their own decisions * Participants undergoing cancer treatment * Participants with an Infection (active cellulitis) * Participants with a known Iodine Allergy * Participants who weigh more than 375 lbs * Participants with cardiac arrhythmias or implanted electronic equipment * Participants who have undergone joint replacement in involved extremity * Participants with cardiac insufficiency

Design outcomes

Primary

MeasureTime frameDescription
Change in The L-dex (Lymphedema Index).18 monthsThe L-DEX score represents the difference in the amount of extracellular fluid in an at-risk limb compared to an unaffected limb.

Secondary

MeasureTime frameDescription
Change in Extracellular Fluid in liters18 monthsAll fluid that is not contained within the cells. Expressed as volume (liters or pints) and percentage of TBW (%).
Change in Intracellular Fluid in liters18 Months• Description: All fluid contained within the cells. Expressed as volume (liters or pints) and percentage of TBW (%).
Change in Skeletal Muscle Mass in lbs18 MonthsThe amount of mass a person has that is made up of fat. Expressed in kgs or lbs and percentage of total weight (%)
Change in Total body weight in liters18 MonthsAll the water within a person's body, including both intracellular and extracellular fluid. Expressed as volume (liters or pints) and percentage of total weight (%).
Change in Free Fat Mass in lbs18 MonthsThe amount of mass a person has that contains no fat (lean body mass). Includes muscle, connective tissue, organs, body water and bone. Expressed in kgs or lbs and percentage of total weight (%).
Change in Basal Metabolic Rate (BMR) in lbs18 MonthsDaily amount of energy a person's body burns when at complete rest. Expressed in calories.
Change in Basal Metabolic Rate in kg/m^218 monthsA relationship between weight and height that is associated with body fat and health risks. BMI = weight / height2.
Change in Fat Mass in lbs18 MonthsThe amount of mass a person has that is made up of fat. Expressed in kgs or lbs and percentage of total weight (%)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026